Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Duseja

Showing results (301-310 of 387) with videos related to

Pageof 39
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2019
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced FibrosisWah-Kheong Chan, Sombat Treeprasertsuk, George Boon-Bee Goh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2018
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant CandidatesZobair Younossi, Maria Stepanova, Janus P Ong, et al.
World Journal of Gastroenterology|June 2, 2020
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiativePanyavee Pitisuttithum, Wah-Kheong Chan, George Boon-Bee Goh, et al.
JCO Global Oncology|November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)Anant Ramaswamy, Anand Kulkarni, George John, et al.
Journal of Gastroenterology and Hepatology|March 19, 2016
Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience, Vivek Saraswat, Shivaram P Singh, et al.
Gastroenterology|August 24, 2024
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination ProgramMadhumita Premkumar, Radha K Dhiman, Ajay Duseja, et al.
Journal of Clinical and Experimental Hepatology|May 6, 2015
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of GastroenterologyAjay Duseja, Shivaram P Singh, Vivek A Saraswat, et al.
BMJ Open|May 2, 2022
COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort studyMadhumita Premkumar, Sekar Loganathan, Kamal Kajal, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Pageof 39

Showing results (301-310 of 387) with videos related to

Sort By:
Pageof 39
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2019
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced FibrosisWah-Kheong Chan, Sombat Treeprasertsuk, George Boon-Bee Goh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2018
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant CandidatesZobair Younossi, Maria Stepanova, Janus P Ong, et al.
World Journal of Gastroenterology|June 2, 2020
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiativePanyavee Pitisuttithum, Wah-Kheong Chan, George Boon-Bee Goh, et al.
JCO Global Oncology|November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)Anant Ramaswamy, Anand Kulkarni, George John, et al.
Journal of Gastroenterology and Hepatology|March 19, 2016
Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience, Vivek Saraswat, Shivaram P Singh, et al.
Gastroenterology|August 24, 2024
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination ProgramMadhumita Premkumar, Radha K Dhiman, Ajay Duseja, et al.
Journal of Clinical and Experimental Hepatology|May 6, 2015
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of GastroenterologyAjay Duseja, Shivaram P Singh, Vivek A Saraswat, et al.
BMJ Open|May 2, 2022
COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort studyMadhumita Premkumar, Sekar Loganathan, Kamal Kajal, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Pageof 39